Ftse Mib
33.280,87
0,16%
DAX
19.146,17
0,76%
S&P 500
5.948,93
0,54%
NASDAQ
18.997,95
0,17%
Bitcoin
98.647,07
4,54%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Lyell Immunopharma Inc (LYEL) Lyell Immunopharma Inc (LYEL) Notizie

Lyell Immunopharma Inc

LYEL
0,9545
-0,0755 (-7,33%)
Ultimo aggiornamento: 20:05:20
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
07/11/202422:09EDGAR2Form 8-K - Current report
07/11/202422:05GLOBELyell Immunopharma Reports Business Highlights and Financial..
05/11/202415:30GLOBELyell Announces Presentation of Initial Clinical Data from..
31/10/202421:45EDGAR2Form 8-K - Current report
31/10/202421:00GLOBELyell Immunopharma Completes Acquisition of ImmPACT Bio
24/10/202422:06EDGAR2Form 8-K - Current report
24/10/202422:00GLOBELyell Immunopharma to Acquire ImmPACT Bio and Prioritizes..
04/10/202415:00GLOBELyell Immunopharma Announces the Acceptance Abstracts for..
24/9/202422:05GLOBELyell Immunopharma Announces Participation in Goldman Sachs..
28/8/202422:05GLOBELyell Immunopharma Announces Participation in September..
07/8/202422:06EDGAR2Form 8-K - Current report
07/8/202422:05GLOBELyell Immunopharma Reports Business Highlights and Financial..
26/6/202413:00GLOBELyell Immunopharma Reports Dose-dependent Clinical Activity..
14/6/202422:07EDGAR2Form 8-K - Current report
03/6/202422:05GLOBELyell Immunopharma to Participate in the Goldman Sachs..
07/5/202422:05GLOBELyell Immunopharma to Participate in BofA Securities Health..
06/5/202414:12EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/5/202414:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/5/202414:03EDGAR2Form 8-K - Current report
06/5/202414:00GLOBELyell Immunopharma Reports Business Highlights and Financial..
05/3/202422:30GLOBELyell Immunopharma Announces the Acceptance of Three..
28/2/202422:07EDGAR2Form 8-K - Current report
28/2/202422:05GLOBELyell Immunopharma Reports Business Highlights and Financial..
26/2/202422:05GLOBELyell Immunopharma Announces Participation in March Investor..
14/2/202402:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202402:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202402:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:05GLOBELyell Immunopharma to Participate in 42nd Annual J.P. Morgan..
Apertura: 1,01 Min: 0,9359 Max: 1,04
Chiusura: 1,03

La tua Cronologia

NASDAQ
LYEL
Lyell Immunopharma
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network